EXTRANEOUS TERMS Bids must conform to the terms set forth in the Bid Documents, as extraneous terms or material deviations (including additional, inconsistent, conflicting or alternative terms) may render the Bid non-responsive and may result in rejection of the Bid. Extraneous term(s) submitted on standard, pre-printed forms (including but not limited to: product literature, order forms, license agreements, contracts or other documents) that are attached or referenced with submissions shall not be considered part of the Bid or resulting Contract, but shall be deemed included for informational or promotional purposes only. Only those extraneous terms that meet all the following requirements may be considered as having been submitted as part of the Bid: a. Each proposed extraneous term (addition, deletion, counter-offer, deviation, or modification) must be specifically enumerated in a writing which is not part of a pre-printed form; and b. The writing must identify the particular specification requirement (if any) that Bidder rejects or proposes to modify by inclusion of the extraneous term; and c. The Bidder shall enumerate the proposed addition, counter offer, modification or deviation from the Bid Document, and the reasons therefore.
Plural Terms All terms defined in this Agreement or any other Credit Document in the singular form shall have comparable meanings when used in the plural form and vice versa.
Other Definitional Terms The words "hereof", "herein" and "hereunder" and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement, and Article, Section, Schedule, Exhibit and like references are to this Agreement unless otherwise specified.
Payments Terms A. The County shall make payments upon the agreed upon price for a specific Job Order as listed in the Notice to Proceed. The County will make progress payments monthly as the Work proceeds on estimates approved by County Project Manager. The Contractor shall furnish a breakdown of the total Contract price showing the amount included therein for each principal category of the Work, to provide a basis for determining progress payments. The County will only pay for actual Work in place. B. Lump sum payment - if an individual Job Order is scheduled for Completion within 45 days or less, the County will make one payment after 30 days of Work to the Contractor, exclusive of retention. Contractor may request for one payment (including retention payment); however, payment will be made after Final Acceptance of the Job Order. C. Partial payment – the County will consider a request for partial payments for Job Orders scheduled for a performance period of greater than 45 days. D. Retention - When payments are made under this Contract, five percent (5%) of each requested and approved payment will be retained. The retention will be released upon Final Acceptance of the Work, and the County’s approval on the final payment request. A Notice of Completion for each individual Job Order must be filed. Final payment is to be made 35 days subsequent to the filing of the Notice of Completion.
INDEX OF DEFINED TERMS Capitalized terms in this Agreement shall have the defined meanings that appear in the provisions of the Agreement listed below. Acceptance Time 5.2(b) Acquisition Proposal 5.2(a) Adverse Recommendation Change 5.2(c) Affiliate 3.3(d) Agreement Preamble Alternative Acquisition Agreement 5.2(c) Assignee 9.5(a) award 3.3(b) Book-Entry Share 2.1(c) business day 9.10(b) CERCLA 3.18(b) Certificate of Merger 1.4 Certificate 2.1(c) Closing 1.5 Closing Amount Recitals Closing Date 1.5 Code 2.6 Company Preamble Company Balance Sheet 3.6(a) Company Board of Directors Recitals Company Disclosure Letter SECTION 3 Company Joint Venture 3.4(c) Company’s knowledge 9.10(b) Company Material Adverse Effect 3.1(a) Company Option 2.4(a) Company Preferred Stock 3.3(a) Company Quarterly Balance Sheet 3.7 Company Restricted Share 2.4(b) Company Restricted Stock 2.4(b) Company Rights 3.3(a) Company Rights Agreement 3.3(a) Company SEC Reports 3.5 Company Stockholder Approval 6.1 Company Stock Plans 2.4(a) Company Subsidiary 3.4(a) Confidentiality Agreement 1.2(c) Continuing Employee 6.11(b) CPR Recitals CPR Agreement Recitals Current D&O Insurance 6.8(b) Delisting Period 6.3 DGCL Recitals Dissenting Shares 2.3(a) DSU 2.4(c) Effective Time 1.4 Employee Release 6.11(d) Environmental Laws 3.18(e)(i) ERISA 3.16(a) ERISA Affiliate 3.16(b) Exchange Act 1.1(a) Exchange Fund 2.2(a) Expiration Date 1.1(a) FCPA 3.9(c) FDA 3.9(d) Good Clinical Practices 3.9(h) Good Laboratory Practices 3.9(h) Good Manufacturing Practices 3.9(i) Governmental Entity 9.10(b) Hazardous Materials 3.18(e)(ii) HSR Act 3.19 IC Plans 6.11(a) Incentive Compensation Plan 6.11(a) Indemnified Parties 6.8(a) Independent Directors 6.9(a) IRS 3.16(a) Laws 3.9(b) Layoff Laws 3.17(b) Maximum Premium 6.8(b) Merger 1.3(a) Merger Agreement Annex I Merger Consideration 2.1(c) Minimum Condition Annex I Notice Period 5.2(d) OECD Convention 3.9(c) Offer Recitals Offer Condition 1.1(a) Offer Documents 1.1(c) Offer Price Recitals Offer to Purchase 1.1(a) on a fully diluted basis 9.10(b) Outside Date 8.1(b)(ii) Parent Preamble Paying Agent 2.2(a) Performance-Based DSU 2.4(c) Permits 3.9 person 9.10(b) Plans 3.16(a) Post-Closing SEC Reports 6.3 Principal Stockholders Recitals Prior Plan 6.11(c) Program 3.9(k) Prohibited Payment 3.9(c) Proprietary Rights 3.12(a) Proxy Statement 1.8(a)(ii) Real Property 3.12(b) Regulation M-A 1.1(c) Release 3.18(e)(iii) Representatives 5.2(a) Reporting Tail Endorsement 6.8(b) Restraints 8.1(b)(i) Rights Agent Recitals Sales Incentive Compensation Plan 6.11(a) Xxxxxxxx-Xxxxx Act 3.6(b) Schedule 14D-9 1.2(b) Schedule TO 1.1(b) SEC 1.1(a) Securities Act 3.11(c) Severance 6.11(d) Shares Recitals Special Meeting 1.8(a)(i) Sub Preamble Sub Common Stock 2.1 Successor Plan 6.11(c) Superior Proposal 5.2(b) Surviving Corporation 1.3(a) Tax 3.15(a) Taxable 3.15(a) Tax Return 3.15(a) Tender Completion Time 6.2 Tender and Voting Agreements Recitals Terminated Employee 6.11(d) Termination Fee 8.2(b) Time-Vested DSU 2.4(c) Top-Up Option 1.10(a) Top-Up Shares 1.10(a) UK Bribery Act 3.9(c) THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of October 24, 2011 is among CUBIST PHARMACEUTICALS, INC. (“Parent”), a Delaware corporation, FRD ACQUISITION CORPORATION (“Sub”), a newly-formed Delaware corporation and a direct or indirect wholly-owned subsidiary of Parent, and ADOLOR CORPORATION (the “Company”), a Delaware corporation.